|
Name |
Methyl 3-oxoheptanoate
|
| Molecular Formula | C8H14O3 | |
| IUPAC Name* |
methyl 3-oxoheptanoate
|
|
| SMILES |
CCCCC(=O)CC(=O)OC
|
|
| InChI |
InChI=1S/C8H14O3/c1-3-4-5-7(9)6-8(10)11-2/h3-6H2,1-2H3
|
|
| InChIKey |
CZTKGERSDUGZPQ-UHFFFAOYSA-N
|
|
| Synonyms |
Methyl 3-oxoheptanoate; 39815-78-6; Methyl valerylacetate; Heptanoic acid, 3-oxo-, methyl ester; 3-Oxoenanthic Acid Methyl Ester; Methyl 3-Oxoenanthate; 3-Oxoheptanoic Acid Methyl Ester; 3-Ketoheptanoic Acid Methyl Ester; METHYL3-OXOHEPTANOATE; Heptansaure-methylester; Methyl Valeric Acetate; methyl-3-oxoheptanoate; Methyl?Valeric?Acetate; Methyl 3-oxoheptanoate #; SCHEMBL662653; 3-Ketoenanthic acid methyl ester; 3-oxo-heptanoic acid methylester; DTXSID40338056; 3-oxo-heptanoic acid methyl ester; ZINC2556891; MFCD00191568; AKOS015855346; DS-3357; BP-10048; CS-0152392; FT-0655438; O0246; H10810; EN300-1440036; A824745; Q-201374; Methyl 3-oxoheptanoate, produced by Wacker Chemie AG, Burghausen, Germany, >=96.0% (GC)
|
|
| CAS | 39815-78-6 | |
| PubChem CID | 546075 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 158.19 | ALogp: | 1.3 |
| HBD: | 0 | HBA: | 3 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 43.4 | Aromatic Rings: | 0 |
| Heavy Atoms: | 11 | QED Weighted: | 0.452 |
| Caco-2 Permeability: | -4.475 | MDCK Permeability: | 0.00004200 |
| Pgp-inhibitor: | 0.096 | Pgp-substrate: | 0.01 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.006 |
| 30% Bioavailability (F30%): | 0.35 |
| Blood-Brain-Barrier Penetration (BBB): | 0.994 | Plasma Protein Binding (PPB): | 28.17% |
| Volume Distribution (VD): | 0.477 | Fu: | 81.08% |
| CYP1A2-inhibitor: | 0.204 | CYP1A2-substrate: | 0.367 |
| CYP2C19-inhibitor: | 0.154 | CYP2C19-substrate: | 0.704 |
| CYP2C9-inhibitor: | 0.065 | CYP2C9-substrate: | 0.481 |
| CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.233 |
| CYP3A4-inhibitor: | 0.022 | CYP3A4-substrate: | 0.227 |
| Clearance (CL): | 8.815 | Half-life (T1/2): | 0.931 |
| hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.043 |
| Drug-inuced Liver Injury (DILI): | 0.371 | AMES Toxicity: | 0.16 |
| Rat Oral Acute Toxicity: | 0.047 | Maximum Recommended Daily Dose: | 0.028 |
| Skin Sensitization: | 0.729 | Carcinogencity: | 0.056 |
| Eye Corrosion: | 0.99 | Eye Irritation: | 0.989 |
| Respiratory Toxicity: | 0.793 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000235 | ![]() |
0.559 | D0OL6O | ![]() |
0.447 | ||
| ENC000232 | ![]() |
0.515 | D0AY9Q | ![]() |
0.365 | ||
| ENC001036 | ![]() |
0.487 | D03ZJE | ![]() |
0.294 | ||
| ENC000253 | ![]() |
0.475 | D0ZI4H | ![]() |
0.286 | ||
| ENC000371 | ![]() |
0.472 | D0Y4AW | ![]() |
0.283 | ||
| ENC001025 | ![]() |
0.432 | D01QLH | ![]() |
0.275 | ||
| ENC000758 | ![]() |
0.415 | D0Y7ZD | ![]() |
0.268 | ||
| ENC000249 | ![]() |
0.413 | D0O4GY | ![]() |
0.262 | ||
| ENC000234 | ![]() |
0.410 | D0A7MY | ![]() |
0.250 | ||
| ENC000735 | ![]() |
0.405 | D0Y3KG | ![]() |
0.250 | ||